Paragon Associates & Paragon Associates II Joint Venture Makes New Investment in ASP Isotopes Inc. (NASDAQ:ASPI)

Paragon Associates & Paragon Associates II Joint Venture purchased a new stake in shares of ASP Isotopes Inc. (NASDAQ:ASPIFree Report) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 25,000 shares of the company’s stock, valued at approximately $113,000. ASP Isotopes comprises 0.3% of Paragon Associates & Paragon Associates II Joint Venture’s portfolio, making the stock its 12th biggest position.

Other institutional investors and hedge funds also recently modified their holdings of the company. Hanson & Doremus Investment Management purchased a new position in ASP Isotopes in the fourth quarter valued at about $27,000. B. Riley Wealth Advisors Inc. purchased a new position in ASP Isotopes in the third quarter valued at approximately $42,000. Avantax Advisory Services Inc. bought a new position in ASP Isotopes during the fourth quarter valued at $45,000. SVB Wealth LLC purchased a new stake in ASP Isotopes in the fourth quarter worth $49,000. Finally, Boston Financial Mangement LLC bought a new stake in shares of ASP Isotopes in the fourth quarter valued at $50,000. 16.80% of the stock is owned by hedge funds and other institutional investors.

ASP Isotopes Stock Up 12.2 %

ASPI stock opened at $4.69 on Tuesday. ASP Isotopes Inc. has a fifty-two week low of $1.86 and a fifty-two week high of $9.33. The stock has a fifty day moving average of $4.99 and a 200-day moving average of $4.95. The company has a market capitalization of $334.82 million, a price-to-earnings ratio of -7.69 and a beta of 3.66. The company has a debt-to-equity ratio of 0.80, a quick ratio of 7.54 and a current ratio of 7.55.

About ASP Isotopes

(Free Report)

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.

Further Reading

Want to see what other hedge funds are holding ASPI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ASP Isotopes Inc. (NASDAQ:ASPIFree Report).

Institutional Ownership by Quarter for ASP Isotopes (NASDAQ:ASPI)

Receive News & Ratings for ASP Isotopes Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ASP Isotopes and related companies with MarketBeat.com's FREE daily email newsletter.